Spero Therapeutics, Inc. (SPRO) NASDAQ
2.80
-0.0346(-1.22%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 130.53M |
| Enterprise Value | 93.16M |
| P/E Ratio | 10.64 |
| PEG Ratio | 0.02 |
| Price/Sales Ratio | 2.99 |
| Price/Book Ratio | 3.06 |
| Enterprise/Revenue | 2.01 |
| Enterprise/EBITDA | 7.8 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.28 |
| Operating Margin | 0.25 |
Management Effectiveness
| Return On Assets | 0.26 |
| Return On Equity | 0.36 |
Income Statement
| Revenue | 59.62M |
| Revenue/Share | 0.96 |
| Gross Profit | 59.62M |
| EBITDA | -24,000 |
| Net Income | 8.57M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 56.13M |
| Total Cash/Share | 0.98 |
| Total Debt | 2.47M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 10.5 |
| Book Value Per Share | 0.92 |
Price History
| 52-Week Change | 3.28 |
| 52-Week High | 3.22 |
| 52-Week Low | 1.8 |
| Moving Average 50 Days | 2.62 |
| Moving Average 200 Days | 2.35 |
Statistics
| Average Volume | 510,422 |
| Shares Outstanding | 57.9M |
| % Held by Institutions | 36.85 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
